Clinical Trials Directory

Trials / Conditions / Stage IVA Pancreatic Cancer

Stage IVA Pancreatic Cancer

11 registered clinical trials studyying Stage IVA Pancreatic Cancer.

StatusTrialSponsorPhase
CompletedPharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
NCT04067960
Mayo ClinicEARLY_Phase 1
CompletedPembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
NCT03095781
Emory UniversityPhase 1
CompletedAPN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid
NCT03087591
Wake Forest University Health SciencesPhase 1
CompletedPalbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
NCT02897375
Emory UniversityPhase 1
TerminatedTLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Pro
NCT02650635
Mayo ClinicPhase 1
CompletedAfatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Can
NCT02451553
University of WashingtonPhase 1
CompletedElectronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in P
NCT02511821
City of Hope Medical CenterN/A
CompletedADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
NCT01825603
University of NebraskaPhase 1
UnknownWeekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
NCT00323583
Seattle Cancer Treatment and Wellness CenterPhase 2
CompletedCombination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the P
NCT00020345
National Institutes of Health Clinical Center (CC)Phase 2
CompletedVaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
NCT00019006
National Cancer Institute (NCI)Phase 1